Nucleus Replacement Devices - Medical Devices Pipeline Assessment, 2018

Nucleus Replacement Devices - Medical Devices Pipeline Assessment, 2018


  • Products Id :- GDME0670EPD
  • |
  • Pages: 66
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Nucleus Replacement Devices-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Nucleus Replacement Devices-Medical Devices Pipeline Assessment, 2018" provides an overview of Nucleus Replacement Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nucleus Replacement Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Nucleus Replacement Devices under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Nucleus Replacement Devices and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Nucleus Replacement Devices under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Nucleus Replacement Devices Overview 6

3 Products under Development 7

3.1 Nucleus Replacement Devices-Pipeline Products by Stage of Development 7

3.2 Nucleus Replacement Devices-Pipeline Products by Territory 8

3.3 Nucleus Replacement Devices-Pipeline Products by Regulatory Path 9

3.4 Nucleus Replacement Devices-Pipeline Products by Estimated Approval Date 10

3.5 Nucleus Replacement Devices-Ongoing Clinical Trials 11

4 Nucleus Replacement Devices-Pipeline Products under Development by Companies 12

4.1 Nucleus Replacement Devices Companies-Pipeline Products by Stage of Development 12

4.2 Nucleus Replacement Devices-Pipeline Products by Stage of Development 13

5 Nucleus Replacement Devices Companies and Product Overview 14

5.1 Arthro Kinetics AG Company Overview 14

5.2 Chi2Gel Ltd. Company Overview 15

5.3 Clariance Inc Company Overview 16

5.4 CryoLife Inc Company Overview 17

5.5 DePuy Synthes Inc Company Overview 18

5.6 Gentis Inc Company Overview 19

5.7 Hydrospine, Inc. Company Overview 20

5.8 Ortho Regenerative Technologies Inc Company Overview 21

5.9 Raymedica, LLC Company Overview 22

5.10 Replication Medical Inc Company Overview 23

5.11 Spine Wave Inc Company Overview 24

5.12 Stryker Corp Company Overview 26

5.13 TranS1 Inc Company Overview 27

5.14 Vertebral Technologies Inc Company Overview 28

5.15 Zimmer Biomet Holdings Inc Company Overview 31

6 Nucleus Replacement Devices-Recent Developments 33

6.1 Jul 10, 2018: Stryker announces organizational changes 33

6.2 Jun 25, 2018: Zimmer Biomet Update on Warsaw North Campus FDA Inspection 33

6.3 Jun 19, 2018: CryoLife Appoints Marna Borgstrom As Board Director 34

6.4 May 17, 2018: SpinalCyte Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2018 34

6.5 May 16, 2018: Zimmer Biomet Statement on Warsaw North Campus FDA Inspection 35

6.6 May 03, 2018: RTI Surgical Announces First Quarter 2018 Results 35

6.7 May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results 36

6.8 Apr 26, 2018: Zimmer Biomet Reports First Quarter 2018 Financial Results 37

6.9 Apr 26, 2018: Stryker reports first quarter 2018 operating results 38

6.10 Apr 04, 2018: RTI Surgical Reaches Global Milestone of Providing 8 Million Biologic Implants with Zero Confirmed Incidence of Implant-Associated Infection 39

6.11 Mar 19, 2018: Zimmer Biomet Appoints Coleman N. Lannum as Senior Vice President of Investor Relations 40

6.12 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results 40

6.13 Mar 01, 2018: RTI Surgical Announces Fourth Quarter and Full Year 2017 Results 41

6.14 Jan 30, 2018: Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 Results 43

6.15 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook 44

6.16 Jan 09, 2018: Stryker provides 2017 preliminary net sales results 46

6.17 Jan 05, 2018: RTI Surgical Outlines 2018 Guidance and Long-Term Goals 46

6.18 Dec 27, 2017: SpinalCyte Announces 25th Patent 47

6.19 Dec 19, 2017: Zimmer Biomet Announces Appointment of Bryan C. Hanson as President and Chief Executive Officer 47

6.20 Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors 48

6.21 Nov 02, 2017: RTI Surgical Announces 2017 Third Quarter Results 49

6.22 Nov 01, 2017: Zimmer Biomet Reports Third Quarter 2017 Financial Results 50

6.23 Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results 51

6.24 Oct 26, 2017: Stryker reports third quarter 2017 results 52

6.25 Oct 04, 2017: Zimmer Biomet Provides Update on Manufacturing Facilities in Guaynabo and Ponce, Puerto Rico 54

6.26 Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors 54

6.27 Sep 20, 2017: SpinalCyte Announces New Australian Patent 55

6.28 Sep 18, 2017: RTI Surgical Continues to Augment Leadership Team to Accelerate its Strategic Direction 55

6.29 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 57

6.30 Aug 08, 2017: RTI Surgical Announces 2017 Second Quarter Results 57

6.31 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 58

6.32 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 59

6.33 Jul 27, 2017: Stryker reports second quarter 2017 results 60

6.34 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 61

6.35 Jul 20, 2017: SpinalCyte Receives New Japanese Patent 62

7 Appendix 63

7.1 Methodology 63

7.2 About GlobalData 66

7.3 Contact Us 66

7.4 Disclaimer 66

1.2 List of Figures

Figure 1: Nucleus Replacement Devices-Pipeline Products by Stage of Development 7

Figure 2: Nucleus Replacement Devices-Pipeline Products by Territory 8

Figure 3: Nucleus Replacement Devices-Pipeline Products by Regulatory Path 9

Figure 4: Nucleus Replacement Devices-Pipeline Products by Estimated Approval Date 10

Figure 5: Nucleus Replacement Devices-Ongoing Clinical Trials 11

1.1 List of Tables

Table 1: Nucleus Replacement Devices-Pipeline Products by Stage of Development 7

Table 2: Nucleus Replacement Devices-Pipeline Products by Territory 8

Table 3: Nucleus Replacement Devices-Pipeline Products by Regulatory Path 9

Table 4: Nucleus Replacement Devices-Pipeline Products by Estimated Approval Date 10

Table 5: Nucleus Replacement Devices-Ongoing Clinical Trials 11

Table 6: Nucleus Replacement Devices Companies-Pipeline Products by Stage of Development 12

Table 7: Nucleus Replacement Devices-Pipeline Products by Stage of Development 13

Table 8: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: NuReS-Product Status 14

Table 10: NuReS-Product Description 14

Table 11: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 15

Table 12: Chi2Disc-Product Status 15

Table 13: Chi2Disc-Product Description 15

Table 14: Clariance Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Table 15: NucleoFill-Product Status 16

Table 16: NucleoFill-Product Description 16

Table 17: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Table 18: Biodisc Nucleus Pulposus Replacement-Product Status 17

Table 19: Biodisc Nucleus Pulposus Replacement-Product Description 17

Table 20: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Table 21: Hydrafil-Product Status 18

Table 22: Hydrafil-Product Description 18

Table 23: Gentis Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Table 24: DiscCell-Product Status 19

Table 25: DiscCell-Product Description 19

Table 26: Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20

Table 27: Intervertebral Disc Repair System-Product Status 20

Table 28: Intervertebral Disc Repair System-Product Description 20

Table 29: Ortho Regenerative Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Table 30: Nucleus Pulposus Repair Device-Product Status 21

Table 31: Nucleus Pulposus Repair Device-Product Description 21

Table 32: Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 22

Table 33: HydraFlex Nucleus Arthroplasty System-Product Status 22

Table 34: HydraFlex Nucleus Arthroplasty System-Product Description 22

Table 35: Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Table 36: NeuDisc-Product Status 23

Table 37: NeuDisc-Product Description 23

Table 38: Spine Wave Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Table 39: NuCore Injectable Nucleus-Product Status 24

Table 40: NuCore Injectable Nucleus-Product Description 24

Table 41: NuCore RPXL Injectable Nucleus-Product Status 25

Table 42: NuCore RPXL Injectable Nucleus-Product Description 25

Table 43: Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview 26

Table 44: Aquarelle-Product Status 26

Table 45: Aquarelle-Product Description 26

Table 46: TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Table 47: Percutaneous Nucleus Replacement Implant-Product Status 27

Table 48: Percutaneous Nucleus Replacement Implant-Product Description 27

Table 49: Vertebral Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Table 50: InterCushion Disc Nucleus Replacement System-Product Status 28

Table 51: InterCushion Disc Nucleus Replacement System-Product Description 28

Table 52: Vertebral Technologies Inc-Ongoing Clinical Trials Overview 29

Table 53: InterCushion Disc Nucleus Replacement System-A Pilot Clinical Study to Assess the Safety and Effectiveness of the InterCushion Disc Nucleus Prosthesis in Patients Receiving Discectomy 30

Table 54: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 55: Newcleus-Product Status 31

Table 56: Newcleus-Product Description 31

Table 57: Regain Lumbar Artificial Disc-Product Status 32

Table 58: Regain Lumbar Artificial Disc-Product Description 32

Table 59: Glossary 65

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Arthro Kinetics AG

Chi2Gel Ltd.

Clariance Inc

CryoLife Inc

DePuy Synthes Inc

Gentis Inc

Hydrospine, Inc.

Ortho Regenerative Technologies Inc

Raymedica, LLC

Replication Medical Inc

Spine Wave Inc

Stryker Corp

TranS1 Inc

Vertebral Technologies Inc

Zimmer Biomet Holdings Inc

Arthro Kinetics AG, NuReS; Chi2Gel Ltd., Chi2Disc; Clariance Inc, NucleoFill; CryoLife Inc, Biodisc Nucleus Pulposus Replacement; DePuy Synthes Inc, Hydrafil; Gentis Inc, DiscCell; Hydrospine, Inc., Intervertebral Disc Repair System; Ortho Regenerative Technologies Inc, Nucleus Pulposus Repair Device; Raymedica, LLC, HydraFlex Nucleus Arthroplasty System; Replication Medical Inc, NeuDisc; Spine Wave Inc, NuCore Injectable Nucleus; Spine Wave Inc, NuCore RPXL Injectable Nucleus; Stryker Corp, Aquarelle; TranS1 Inc, Percutaneous Nucleus Replacement Implant; Vertebral Technologies Inc, InterCushion Disc Nucleus Replacement System; Zimmer Biomet Holdings Inc, Newcleus; Zimmer Biomet Holdings Inc, Regain Lumbar Artificial Disc

select a license
Single User License
USD 2500 INR 178325
Site License
USD 5000 INR 356650
Corporate User License
USD 7500 INR 534975

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com